G. Pogátsa-Murray

发表

Incomplete Inhibition of Platelet Aggregation and Glycoprotein IIb-IIIa Receptor Blockade by Abciximab: Importance of Internal Pool of Glycoprotein IIb-IIIa Receptors

A. Schömig, Timm L. Dickfeld, M. Gawaz, 2000, Thrombosis and Haemostasis.

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, Journal of the American College of Cardiology.

Coronary heart disease A double-blind , randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days

A. Wieczorek, A. Kastrati, A. Schömig, 2007 .

Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel: Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial

A. Kastrati, A. Schömig, E. Schömig, 2005, Circulation.

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, JAMA.

Adhesion of monocyte very late antigen-4 to endothelial vascular cell adhesion molecule-1 induces interleukin-1beta-dependent expression of interleukin-6 in endothelial cells.

F. Neumann, A. Schömig, K. Brand, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis.

F. Neumann, A. Schömig, M. Gawaz, 2000, Atherosclerosis.

Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement.

A. Kastrati, F. Neumann, M. Seyfarth, 2000, Circulation.

Expression of CXCR4, VLA-1, LFA-3 and transducer of ERB in G-CSF-mobilised progenitor cells in acute myocardial infarction

A. Kastrati, A. Schömig, I. Ott, 2010, Thrombosis and Haemostasis.

Effect of Glycoprotein IIb-IIIa Receptor Antagonism on Platelet Membrane Glycoproteins after Coronary Stent Placement

F. Neumann, A. Schömig, M. Gawaz, 1998, Thrombosis and Haemostasis.

Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting.

F. Neumann, A. Schömig, M. Gawaz, 2001, Journal of the American College of Cardiology.

Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness

A. Wieczorek, A. Kastrati, A. Schömig, 2006, Thrombosis and Haemostasis.

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

M. Seyfarth, A. Schömig, M. Gawaz, 2001, Heart.

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial

A. Kastrati, J. Mehilli, F. Neumann, 2001, The Lancet.

Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.

M. Seyfarth, A. Schömig, M. Gawaz, 2001, The American journal of cardiology.

, Melchior Placement Previous Cytomegalovirus Infection and Risk of Coronary Thrombotic Events After Stent

A. Kastrati, F. Neumann, M. Seyfarth, 1999 .

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Circulation.

Loading With 600 mg Clopidogrel in Patients With Coronary Artery Disease With and Without Chronic Clopidogrel Therapy

A. Kastrati, A. Schömig, N. von Beckerath, 2004, Circulation.

A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite

A. Wieczorek, A. Kastrati, A. Schömig, 2005, Thrombosis and Haemostasis.

Previous Cytomegalovirus Infection and Restenosis After Coronary Stent Placement

A. Kastrati, J. Mehilli, F. Neumann, 2001, Circulation.

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.

A. Kastrati, J. Mehilli, F. Neumann, 2001, Lancet.

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.

Li Zhang, A. Kastrati, D. Sibbing, 2008, European heart journal.